Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
31.10.25
/
50%
€167.00
Target price
31.10.26
-
Performance (%)
6.59%
Price
26.11.25
€177.00
Summary
This prediction is currently active. With a performance of 6.59%, the BUY prediction by The_Goldman_Sachs_Gr for Insmed Inc. is trending in the right direction. This prediction currently runs until 31.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Insmed Inc. | 3.488% |
| iShares Core DAX® | 2.119% |
| iShares Nasdaq 100 | 1.877% |
| iShares Nikkei 225® | 1.760% |
| iShares S&P 500 | 1.962% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for INSM provided by MarketBeat